These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1532858)

  • 21. Modern external beam radiation therapy for refractory dissecting cellulitis of the scalp.
    Chinnaiyan P; Tena LB; Brenner MJ; Welsh JS
    Br J Dermatol; 2005 Apr; 152(4):777-9. PubMed ID: 15840113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of infliximab in the treatment of follicular occlusion triad].
    Deschamps ME; Payet S; Tournadre A; Soubrier M; Souteyrand P; D'Incan M
    Ann Dermatol Venereol; 2010; 137(8-9):546-50. PubMed ID: 20804900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutis verticis gyrata secondary to acne scleroticans capitis.
    Plewig G
    J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):772-4. PubMed ID: 16268896
    [No Abstract]   [Full Text] [Related]  

  • 24. Musculoskeletal syndromes associated with acne.
    Knitzer RH; Needleman BW
    Semin Arthritis Rheum; 1991 Feb; 20(4):247-55. PubMed ID: 1828308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analyzing the Efficacy of Isotretinoin in Treating Dissecting Cellulitis: A Literature Review and Meta-Analysis.
    Guo W; Zhu C; Stevens G; Silverstein D
    Drugs R D; 2021 Mar; 21(1):29-37. PubMed ID: 33387328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical therapy in a patient with Keratosis-Ichthyosis-Deafness (KID) syndrome associated with follicular occlusion triad.
    Wenghoefer M; Allam JP; Novak N; Maintz L; Martini M; Bergé S
    Eur J Dermatol; 2007; 17(5):449-50. PubMed ID: 17673397
    [No Abstract]   [Full Text] [Related]  

  • 27. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
    Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M
    Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab.
    Babalola F; Chima M; Jobarteh R; Gottlieb A
    J Drugs Dermatol; 2022 Mar; 21(3):313-314. PubMed ID: 35254754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The follicular occlusion triad.
    Montes LF; Curtis AC
    Postgrad Med; 1968 Feb; 43(2):108-12. PubMed ID: 4230193
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of acne conglobata with modern external beam radiation.
    Myers JN; Mason AR; Gillespie LK; Salkey KS
    J Am Acad Dermatol; 2010 May; 62(5):861-3. PubMed ID: 19665259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicular occlusion triad in a follicular blocking disease (pityriasis rubra pilaris).
    Bergeron JR; Stone OJ
    Dermatologica; 1968; 136(5):362-7. PubMed ID: 4232636
    [No Abstract]   [Full Text] [Related]  

  • 32. An Up-to-Date Approach to the Management of Dissecting Cellulitis.
    Nussbaum D; Desai S; Nelson K; Saardi K; Friedman A
    J Drugs Dermatol; 2022 Jul; 21(7):800-802. PubMed ID: 35816064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.
    Canoui-Poitrine F; Revuz JE; Wolkenstein P; Viallette C; Gabison G; Pouget F; Poli F; Faye O; Bastuji-Garin S
    J Am Acad Dermatol; 2009 Jul; 61(1):51-7. PubMed ID: 19406505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting cellulitis of the scalp with typical clinical features: A retrospective cross-sectional study in a Department of Dermatology, Beijing, China.
    Jiang T; Liu C
    J Dermatol; 2022 Nov; 49(11):1173-1177. PubMed ID: 35996875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular occlusion triad: an isotopic response or adverse effect of rituximab?
    Au J; Gibson FT; Aronson IK
    Dermatol Online J; 2020 Feb; 26(2):. PubMed ID: 32239887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): a comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa.
    Scheinfeld N
    Dermatol Online J; 2014 May; 20(5):22692. PubMed ID: 24852785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting cellulitis of the scalp with associated spondylarthropathy: case report and review.
    Salim A; David J; Holder J
    J Eur Acad Dermatol Venereol; 2003 Nov; 17(6):689-91. PubMed ID: 14761139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are dissecting cellulitis and hidradenitis suppurativa different diseases?
    Federico A; Rossi A; Caro G; Magri F; Muscianese M; Di Fraia M; Carlesimo M
    Clin Dermatol; 2021; 39(3):496-499. PubMed ID: 34518010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hidradenitis suppurativa with perifolliculitis capitis abscedens et suffodiens successfully treated with a human anti-tumour necrosis factor monoclonal antibody.
    Minakawa S; Matsuzaki Y; Rokunohe D; Kumagai N; Kurose A; Kushibiki M; Kayaba H; Sawamura D
    Clin Exp Dermatol; 2021 Dec; 46(8):1586-1588. PubMed ID: 34096639
    [No Abstract]   [Full Text] [Related]  

  • 40. Hidradenitis suppurativa and acne conglobata associated with spondyloarthropathy.
    Leybishkis B; Fasseas P; Ryan KF; Roy R
    Am J Med Sci; 2001 Mar; 321(3):195-7. PubMed ID: 11269796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.